Showing results (41-50 of 47) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Neurology|October 1, 1986
Multiple sclerosis: increased expression of interleukin-2 receptors on lymphocytesK Selmaj, C Plater-Zyberk, K A Rockett, et al.European Journal of Neurology|December 6, 2005
EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapsesF Sellebjerg, D Barnes, G Filippini, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|September 14, 2010
Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled studyG Comi, O Abramsky, T Arbizu, et al.European Journal of Neurology|January 26, 2016
Daclizumab high-yield process reduced the evolution of new gadolinium-enhancing lesions to T1 black holes in patients with relapsing-remitting multiple sclerosisE-W Radue, T Sprenger, T Vollmer, et al.Journal of Neurology|February 19, 2014
A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosisT L Vollmer, P S Sorensen, K Selmaj, et al.European Journal of Neurology|January 21, 2018
ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosisX Montalban, R Gold, A J Thompson, et al.Journal of Neurology|December 14, 2004
Escalating immunotherapy of multiple sclerosis--new aspects and practical applicationP Rieckmann, K V Toyka, C Bassetti, et al.Pageof 5